Skip to main content

Magnus Persson to Resign from Immunicum’s Board of Directors

Written by Customer Service on . Posted in Public Companies.

Press Release29 October 2020 Magnus Persson to Resign from Immunicum’s Board of DirectorsImmunicum AB (publ: IMMU.ST) announced today that Magnus Persson will step down from his position as a Board member of Immunicum, following a need for him to spend his time on the new life science fund that he has just started.“As a member of the Board since 2015, I have enjoyed the cooperation with Michael Oredsson, my fellow Board members, and the management. I am especially happy to have assisted in the recruitment of Sven Rohmann as the new CEO. Sven has the expertise required to realize Immunicum’s great potential,” said Magnus Persson.“The Board thanks Magnus for his efforts and contributions to the Company over recent years. We wish Magnus every success in his new assignment,” said Michael Oredsson, Chairman of Immunicum’s Board of Directors.Following Magnus Persson’s resignation, the Board will be composed of six members. According to the Articles of Association’s, the Board must include a minimum of three and a maximum of eight members.The information contained in this report is that which Immunicum (publ), is obliged to publish in accordance with the Swedish Securities Market Act (SFS 2007:528). The information was submitted for publication, through the agency of the contact persons set out below, on October 29, 2020, at 8:00 am CET.FOR MORE INFORMATION, PLEASE CONTACT:Michael Oredsson, Chairman, Immunicum
Telephone: +46 (8) 70 732 8400
E-mail: info@immunicum.comAttachment20201029-Immunicum – Magnus Persson Resigns from Board_ENG

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.